# FDA Inspection 1195342 - Anicare Pharmaceuticals Pvt Ltd. - January 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/anicare-pharmaceuticals-pvt-ltd/8abf3923-4f0b-4ad4-9720-6feda23b7fa1
Source feed: FDA_Inspections

> FDA Inspection 1195342 for Anicare Pharmaceuticals Pvt Ltd. on January 20, 2023. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195342
- Company Name: Anicare Pharmaceuticals Pvt Ltd.
- Inspection Date: 2023-01-20
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1061011 - 2018-08-03](https://www.keypedia.com/records/fda_inspections/anicare-pharmaceuticals-pvt-ltd/530ba2e2-557c-49b1-b242-3a199c99afb1)
- [FDA Inspection 978860 - 2016-07-14](https://www.keypedia.com/records/fda_inspections/anicare-pharmaceuticals-pvt-ltd/87f57b04-5482-41b6-92a3-a6f25fdc4929)

Company: https://www.keypedia.com/companies/anicare-pharmaceuticals-pvt-ltd/27a62bcb-3beb-47a7-9f76-acc526f0388f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c